Bree Foley

3.2k total citations · 2 hit papers
33 papers, 2.5k citations indexed

About

Bree Foley is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Bree Foley has authored 33 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 11 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Bree Foley's work include Immune Cell Function and Interaction (24 papers), T-cell and B-cell Immunology (18 papers) and CAR-T cell therapy research (11 papers). Bree Foley is often cited by papers focused on Immune Cell Function and Interaction (24 papers), T-cell and B-cell Immunology (18 papers) and CAR-T cell therapy research (11 papers). Bree Foley collaborates with scholars based in Australia, United States and Germany. Bree Foley's co-authors include Jeffrey S. Miller, Xianghua Luo, Sarah Cooley, Michael R. Verneris, Daniel J. Weisdorf, Julie Curtsinger, Bin Zhang, Bruce Walcheck, Lewis L. Lanier and Sandra López‐Vergès and has published in prestigious journals such as Blood, Immunity and The Journal of Immunology.

In The Last Decade

Bree Foley

33 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function

2015 551 citations Heinrich Schlums, Frank Cichocki et al. Immunity profile →
Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function

2011 491 citations Bree Foley, Sarah Cooley et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bree Foley Australia	17	2.2k	778	542	466	175	33	2.5k
Frank Cichocki United States	26	2.3k 1.0×	1.0k 1.3×	361 0.7×	330 0.7×	449 2.6×	71	2.7k
Neil T. Young United Kingdom	20	3.0k 1.4×	589 0.8×	417 0.8×	379 0.8×	195 1.1×	51	3.4k
Christelle Retière France	21	1.9k 0.8×	333 0.4×	604 1.1×	343 0.7×	105 0.6×	60	2.2k
Stefania Marcenaro Italy	16	2.8k 1.2×	894 1.1×	169 0.3×	735 1.6×	239 1.4×	20	3.0k
Christopher A. O'Callaghan United Kingdom	8	2.3k 1.0×	449 0.6×	269 0.5×	153 0.3×	181 1.0×	9	2.5k
D Reviron France	21	1.8k 0.8×	551 0.7×	206 0.4×	721 1.5×	138 0.8×	60	2.7k
Ann‐Margaret Little United Kingdom	24	1.2k 0.6×	234 0.3×	259 0.5×	322 0.7×	232 1.3×	55	1.8k
Andreas T. Björklund Sweden	15	1.8k 0.8×	662 0.9×	308 0.6×	465 1.0×	149 0.9×	23	2.1k
Heinrich Schlums Sweden	16	1.7k 0.7×	399 0.5×	258 0.5×	199 0.4×	138 0.8×	24	1.8k
Paola Rivera Italy	9	2.1k 0.9×	768 1.0×	130 0.2×	288 0.6×	210 1.2×	18	2.3k

Countries citing papers authored by Bree Foley

Since Specialization

Citations

This map shows the geographic impact of Bree Foley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bree Foley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bree Foley more than expected).

Fields of papers citing papers by Bree Foley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bree Foley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bree Foley. The network helps show where Bree Foley may publish in the future.

Co-authorship network of co-authors of Bree Foley

This figure shows the co-authorship network connecting the top 25 collaborators of Bree Foley. A scholar is included among the top collaborators of Bree Foley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bree Foley. Bree Foley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Buzzai, Anthony, Emma de Jong, Michael Serralha, et al.. (2025). Interleukin-4 modulates type I interferon to augment antitumor immunity. Science Advances. 11(20). eadt3618–eadt3618. 3 indexed citations

Fernández, Sònia, et al.. (2022). Type I interferon subtypes differentially activate the anti-leukaemic function of natural killer cells. Frontiers in Immunology. 13. 1050718–1050718. 12 indexed citations

Jong, Emma de, et al.. (2021). Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies. Frontiers in Immunology. 12. 765705–765705. 11 indexed citations

Wagner, Teagan, Anthony Buzzai, Ben Wylie, et al.. (2021). IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies. Frontiers in Immunology. 12. 735133–735133. 18 indexed citations

Buzzai, Anthony, Teagan Wagner, Lucy Barrett, et al.. (2020). Diverse Anti-Tumor Immune Potential Driven by Individual IFNα Subtypes. Frontiers in Immunology. 11. 542–542. 12 indexed citations

Foley, Bree, et al.. (2020). Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV). International Journal of Molecular Sciences. 21(22). 8864–8864. 22 indexed citations

Foley, Bree, Emma de Jong, Michelle Nguyen, et al.. (2020). Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B‐ and T‐cell acute lymphoblastic leukaemia. Clinical & Translational Immunology. 9(7). e1151–e1151. 9 indexed citations

Wylie, Ben, Anthony Buzzai, Teagan Wagner, et al.. (2019). CD8+XCR1neg Dendritic Cells Express High Levels of Toll-Like Receptor 5 and a Unique Complement of Endocytic Receptors. Frontiers in Immunology. 9. 2990–2990. 10 indexed citations

Chee, Jonathan, Anthony Buzzai, Ben Wylie, et al.. (2019). Impaired T cell proliferation byex vivoBET-inhibition impedes adoptive immunotherapy in a murine melanoma model. Epigenetics. 15(1-2). 134–144. 6 indexed citations

10.

Cheung, Laurence C., Jennifer Tickner, Meegan Howlett, et al.. (2018). New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment. Leukemia. 32(11). 2326–2338. 29 indexed citations

11.

Fear, Vanessa S., Wee Peng Poh, Jason Waithman, et al.. (2016). Timing of excision after a non-severe burn has a significant impact on the subsequent immune response in a murine model. Burns. 42(4). 815–824. 16 indexed citations

12.

Schlums, Heinrich, Frank Cichocki, Bianca Tesi, et al.. (2015). Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function. Immunity. 42(3). 443–456. 551 indexed citations breakdown →

13.

Wylie, Ben, Elke Seppanen, Kun Xiao, et al.. (2015). Cross-presentation of cutaneous melanoma antigen by migratory XCR1⁺CD103⁻and XCR1⁺CD103⁺dendritic cells. OncoImmunology. 4(8). e1019198–e1019198. 30 indexed citations

14.

Wiernik, Andres, Bree Foley, Bin Zhang, et al.. (2013). Targeting Natural Killer Cells to Acute Myeloid LeukemiaIn Vitrowith a CD16 × 33 Bispecific Killer Cell Engager and ADAM17 Inhibition. Clinical Cancer Research. 19(14). 3844–3855. 176 indexed citations

15.

Santis, Dianne De, Bree Foley, Campbell S. Witt, & Frank Christiansen. (2012). The Detection of NK Cell Alloreactivity by Flow Cytometric CD107a Assay. Methods in molecular biology. 882. 477–489. 3 indexed citations

16.

Foley, Bree, Sarah Cooley, Michael R. Verneris, et al.. (2011). Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood. 119(11). 2665–2674. 491 indexed citations breakdown →

17.

Kostenko, Lyudmila, Lars Kjer‐Nielsen, I. Nicholson, et al.. (2011). Rapid screening for the detection of HLA‐B57 and HLA‐B58 in prevention of drug hypersensitivity. Tissue Antigens. 78(1). 11–20. 34 indexed citations

18.

Foley, Bree, Michael R. Verneris, Julie Curtsinger, et al.. (2011). Natural Killer (NK) Cells Respond to CMV Reactivation After Allogeneic Transplantation with An Increase in NKG2C+CD57+ Self-KIR+ NK Cells with Potent IFNγ Production. Blood. 118(21). 356–356. 1 indexed citations

19.

Santis, Dianne De, et al.. (2009). Rapid, Flow Cytometric Assay for NK Alloreactivity Reveals Exceptions to Rules Governing Alloreactivity. Biology of Blood and Marrow Transplantation. 16(2). 179–191. 9 indexed citations

20.

Foley, Bree, et al.. (2008). KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals. International Immunology. 20(4). 555–563. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact